Norris Medicines

17.14
-0.20
(-1.15%)
Market Cap
17.10 Cr
EPS
-1.19
PE Ratio
-
Dividend Yield
0.00 %
52 Week High
27.74
52 Week Low
10.70
PB Ratio
-1.21
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
272.52
#1 21,304.92
16.12
#1 89,609.60
12.69
#1 1,239
15.84
70.10
56.88
8,532.00
53.12
204.30
-94.36
192
-93.36
55.08
383.90
6,136.69
224.09
1.00
-23.08
0
13.30
66.72
525.55
3,699.87
20.80
961.40
9.35
204
401.80
54.33
69.07
2,319.03
487.22
70.60
-9.60
3
-12.50
49.72
104.47
1,865.36
491.90
146.40
-48.78
-51
450.00
39.53
440.10
1,569.98
53.60
78.10
6,408.33
20
-1.89
59.12
159.50
1,559.50
80.07
7.10
#1 8,85,900.00
-3
#1 876.92
64.64
98.54
1,210.89
30.14
131.90
108.37
12
262.79
51.43
37,999.00
1,167.97
#1 8.89
80.80
15.93
124
-65.60
57.10
Growth Rate
Revenue Growth
-32.14 %
Net Income Growth
-29.41 %
Cash Flow Change
-85.83 %
ROE
-38.05 %
ROCE
-385.96 %
EBITDA Margin (Avg.)
-124.66 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
19
19
21
14
16
8
12
10
8
6
5
Expenses
17
18
21
16
17
10
14
10
7
6
4
EBITDA
2
1
0
-2
-1
-2
-2
0
1
-0
0
Operating Profit %
9 %
4 %
-0 %
-14 %
-4 %
-27 %
-14 %
-1 %
11 %
-3 %
-1 %
Depreciation
1
1
1
1
1
1
1
1
1
1
0
Interest
1
1
1
1
1
1
2
2
2
0
0
Profit Before Tax
0
-0
-1
-3
-2
-4
-4
-2
-1
-1
-1
Tax
1
-0
-0
-1
-0
-1
1
1
1
0
0
Net Profit
-1
0
-1
-3
-2
-3
-5
-3
-2
-1
-1
EPS in ₹
-1.04
0.04
-0.77
-2.51
-1.68
-2.84
-4.96
-3.26
-1.75
-1.19
-0.80

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
18
18
22
21
20
21
20
14
14
14
Fixed Assets
9
8
10
9
9
8
8
7
7
6
Current Assets
7
7
9
8
7
7
8
4
5
6
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
10
10
12
11
12
12
12
7
7
8
Total Liabilities
18
18
22
21
20
21
20
14
14
14
Current Liabilities
5
5
10
11
9
8
12
7
8
9
Non Current Liabilities
8
8
8
8
11
15
16
18
18
19
Total Equity
5
5
5
2
0
-3
-7
-11
-12
-14
Reserve & Surplus
-5
-5
-5
-8
-10
-12
-17
-21
-22
-24
Share Capital
10
10
10
10
10
10
10
10
10
10

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-2
-0
0
0
0
0
0
0
0
0
Investing Activities
-1
-0
-2
-0
-0
0
-0
-0
0
0
Operating Activities
-1
1
-1
1
-2
-3
1
-1
1
0
Financing Activities
0
-1
3
-1
2
3
-1
1
-1
-0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
34.04 %
34.04 %
34.04 %
34.04 %
34.04 %
34.04 %
34.04 %
34.04 %
34.04 %
34.01 %
34.01 %
34.01 %
34.01 %
34.01 %
34.01 %
34.00 %
34.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
20.60 %
20.57 %
20.56 %
20.52 %
20.60 %
20.59 %
20.60 %
20.59 %
20.56 %
20.63 %
20.66 %
20.67 %
20.70 %
20.71 %
20.72 %
20.73 %
20.76 %
Others
45.29 %
45.31 %
45.32 %
45.36 %
45.29 %
45.30 %
45.28 %
45.30 %
45.33 %
45.29 %
45.25 %
45.25 %
45.22 %
45.21 %
45.20 %
45.21 %
45.17 %
No of Share Holders
0
25,010
25,032
25,019
25,141
25,290
25,294
25,329
25,326
25,256
25,242
25,317
25,517
25,400
25,498
25,659
25,815

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
13 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Feb 2025 22.20 21.56
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 22.84 26.42
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 17.59 17.76
30 Jan 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
30 Jan 2024 13.36 22.21
14 Dec 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
14 Dec 2023 11.19 12.23

Announcements

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Closure of Trading WindowMar 29, 2025
Integrated Filing (Financial)Feb 14, 2025
Outcome Of Board Meeting Held On 13Th February 2025 Pursuant To Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Feb 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated (Board Meeting Date) Pursuant To Regulation 30 And 31A (8) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Feb 13, 2025
Board Meeting Intimation for Notice Of The Board Meeting Of 2024-25 Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Feb 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2025
Closure of Trading WindowDec 31, 2024
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 For Receipt Of Request Letter From Promoter Of The Company For Reclassification From Promoter & Promoter Group To Public Category.Dec 23, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementDec 06, 2024
Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For Half Year Ended 30.09.2024.Nov 14, 2024
Adoption Of Financials In Board Meeting Held On Thursday, 14Th November, 2024 Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.Nov 14, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday, 14Th November, 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.Nov 14, 2024
Board Meeting Intimation for Notice Of The Board Meeting Of 2024-25 Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.Nov 11, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 14, 2024
Result Of Voting And Scrutinizers Report - 33Rd AGM Held On 30Th September 2024.Oct 01, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportOct 01, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2024
Intimation Of Change In Board Of Directors Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Sep 30, 2024
Closure of Trading WindowSep 27, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorSep 25, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementSep 25, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 25Th September, 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.Sep 25, 2024
The Cut-Off Date For Determining The Eligibility Of Members To Avail The Facility Of Remote E-Voting Will Be Monday, 23Rd September, 2024.Sep 15, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 10, 2024
Notice Of 33Rd AGM For The Financial Year 2023-24Sep 06, 2024
Reg. 34 (1) Annual Report.Sep 06, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 24, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday, 14Th August, 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.Aug 14, 2024
Board Meeting Intimation for Notice Of The 2Nd Board Meeting Of 2024-25 Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.Aug 09, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 09, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementJul 03, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementJun 29, 2024
Closure of Trading WindowJun 28, 2024
Audited Financial Results For The Quarter And Year Ended March 31 2024May 29, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th May, 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015May 29, 2024
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2024May 22, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 29Th April, 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015Apr 29, 2024
Compliance Certificate As Per Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2024.Apr 27, 2024
Compliance Certificate Pursuant To Regulation 7 (3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015Apr 24, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 08, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 29-04-2024Mar 29, 2024
Closure of Trading WindowMar 22, 2024
Board Meeting Outcome for Outcome Of Independent Directors MeetingMar 22, 2024
Outcome Of The Board Meeting Held Today And Financial Results For Dec 31, 2023Feb 14, 2024
Board Meeting Intimation for December Quarter ResultsFeb 08, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJan 30, 2024
Shareholder Meeting / Postal Ballot-Outcome of EGMJan 30, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jan 15, 2024

Technical Indicators

RSI(14)
Neutral
51.91
ATR(14)
Volatile
1.60
STOCH(9,6)
Neutral
52.84
STOCH RSI(14)
Overbought
86.32
MACD(12,26)
Bullish
0.14
ADX(14)
Weak Trend
24.28
UO(9)
Bearish
55.04
ROC(12)
Uptrend And Accelerating
4.27
WillR(14)
Neutral
-40.89